Evidence map›Paper›PMID 21551058›Full record

ArticleScience (New York, N.Y.)2011

Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum.

Sean C Bendall, Erin F Simonds, Peng Qiu, El-ad D Amir, Peter O Krutzik, Rachel Finck, Robert V Bruggner, Rachel Melamed, Angelica Trejo, Olga I Ornatsky and 6 more

Registry-linked trialAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02441543 (Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus), which is not on this map. Cited by 1,129 papers.

0numbers the graph read from it
0cells of the map it votes in
1,129citing papers in PubMed
61.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02441543 completednot on this mapstarted 2015, after this paper: background citation

Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus

TypeobservationalSponsorIstituto Clinico HumanitasRan2015 to 2018Enrolled45ConditionsSOLID TUMOR
3 · Its place in the literature

Who cites it

1,129 citing papers in PubMed, 2,337 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. AdipocyteCells · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,069 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Sean C BendallBaxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University, Stanford, CA 94305, USA.
Erin F Simonds
Peng Qiu
El-ad D Amir
Peter O Krutzik
Rachel Finck
Robert V Bruggner
Rachel Melamed
Angelica Trejo
Olga I Ornatsky
Robert S Balderas
Sylvia K Plevritis
Karen Sachs
Dana Pe'er
Scott D Tanner
Garry P Nolan
Baxter (United States) · USStanford University · USColumbia University · USUniversity of Toronto · CA

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
TRIGGERING CELL DEATH IN B CELL LYMPHOMAP01CA034233 · NCI · STANFORD UNIVERSITY · PI LEVY, RONALD · 1985 to 2010
$19.5M
TRANS-NETWORK PROJECTSU54CA143907 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HILLIS, WILLIAM DANIEL · 2009 to 2013
$15.2M
MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMAU54CA149145 · NCI · STANFORD UNIVERSITY · PI PLEVRITIS, SYLVIA KATINA · 2010 to 2014
$12.1M
The Center for Systemic Control of Cyto-NetworksPN2EY018228 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HO, CHIH-MING · 2006 to 2010
$8.2M
Software & Hardware Inference Engines for Automated Determination of Primary CellR01CA130826 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2008 to 2011
$6.7M
NCI NIH HHS 1R01CA130826NCI NIH HHS 5U54 CA143907NCI NIH HHS P01 CA034233NCI NIH HHS R01 CA130826NCI NIH HHS U54 CA143907NCI NIH HHS U54 CA149145NEI NIH HHS PN2 EY018228NHLBI NIH HHS HHSN268201000034CNHLBI NIH HHS N0I-HV-00242NIAID NIH HHS U19 AI057229NLM NIH HHS T15 LM007033PHS HHS 272200700038CPHS HHS RB2-01592
6 · The paper itself

Abstract

Flow cytometry is an essential tool for dissecting the functional complexity of hematopoiesis. We used single-cell "mass cytometry" to examine healthy human bone marrow, measuring 34 parameters simultaneously in single cells (binding of 31 antibodies, viability, DNA content, and relative cell size). The signaling behavior of cell subsets spanning a defined hematopoietic hierarchy was monitored with 18 simultaneous markers of functional signaling states perturbed by a set of ex vivo stimuli and inhibitors. The data set allowed for an algorithmically driven assembly of related cell types defined by surface antigen expression, providing a superimposable map of cell signaling responses in combination with drug inhibition. Visualized in this manner, the analysis revealed previously unappreciated instances of both precise signaling responses that were bounded within conventionally defined cell subsets and more continuous phosphorylation responses that crossed cell population boundaries in unexpected manners yet tracked closely with cellular phenotype. Collectively, such single-cell analyses provide system-wide views of immune signaling in healthy human hematopoiesis, against which drug action and disease can be compared for mechanistic studies and pharmacologic intervention.

Indexed as

Signal TransductionAlgorithmsAntibodiesAntigens, SurfaceB-LymphocytesBone Marrow CellsCytokinesDasatinibFlow CytometryHematopoiesisHumansImmunophenotypingLanthanoid Series ElementsLeukocytes, MononuclearLymphocyte ActivationLymphocyte SubsetsAntibodiesAntigens, SurfaceCytokinesDasatinibLanthanoid Series ElementsProtein Kinase InhibitorsProtein-Tyrosine KinasesPyrimidinesThiazolesTransition Elements

Identifiers

PMID21551058
PMCPMC3273988
OpenAlexW2024626836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.